Delayed hypersensitivity reaction with infliximab: unusual to occur after initial dose.
Mazer R
MR
Ally
John D
JD
Betteridge
Ganesh R
GR
Veerappan
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D000069285:Infliximab; D008297:Male; D011379:Prognosis
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab